Skip to main content
Premium Trial:

Request an Annual Quote

Lion Biosciences Licenses SRS to Italy s Siena Biotech

NEW YORK, Dec. 19-Lion Biosciences said today that it has licensed its SRS Evolution bioinformatics system to Siena Biotech, an Italian biomedical company interested in central nervous system and cancer drug development.

 

This company is Lion's third Italian customer.

 

Siena Biotech, situated in Siena, Italy, is owned by the nonprofit Monte dei Paschi Foundation.